Myricetin has been demonstrated to modulate cell pathways essential for supporting tumor cell survival such as PI3K/Akt pathway, nrf signaling, canonical and non-canonical wnt pathway, mTOR pathway, Ras/Raf pathway and JAK/STAT pathway. The gene discussed is NKRF; the disease is neoplasm.